Rheonix COVID-19 MDx Assay

RETURN TO MAIN SCREEN

Rheonix COVID-19 MDx Assay

Export this page in pdf
Disease target
SARS-CoV-2
Regulatory status
US FDA EUA
Time to result
5
Assay target
RNA
Test format
NAT reagent kit – proprietary platform
Technology principle
qRT-PCR
Target analyte
N gene
Level of automation
Fully automated (including sample preparation)
Laboratory/Point-of-care
Lab-based
Self-testing/Self-Collection
Intended for professional use only
Validated sample types
Bronchoalveolar lavage
Mid-turbinate swab
Nasal swab
Nasopharyngeal swab
Oropharyngeal swab
Saliva
Connectivity
Yes
IMPACT OF SARS-COV-2 VARIANT:
Alpha - No expected impact (in silico analyses)
Beta - No expected impact (in silico analyses)
Gamma - Unknown
Manufacturer performance data
Sensitivity
0%
Specificity
0%